'Angina Attack' Category
-
Investment Opportunities In 10 Big Pharmaceutical Companies – Seeking Alpha
"There’s nothing more powerful than an idea whose time has come", said Victor Hugo (1802-1885), recognized as the most influential French writer and poet of the 19th century. The man who brought us "Les Miserables" and "The Hunchback of Notre Dame" has been proven right on the above quote time and time again.
-
Improved technology may obviate need for drug when assessing patients for a coronary stent
In England, it is estimated that one in seven men and one in 12 women over the age of 65 experience chest pain called angina caused by narrowing of the arteries in the heart. around 60,000 such patients a year are fitted with a coronary stent – a wire mesh tube that acts as a [...]
-
Results of the TWENTE trial reported at TCT 2011
Public release date: 11-Nov-2011 [ | E-mail | Share ] Contact: Judy Cardiovascular Research Foundation
-
The Press Association: Older heart patient care 'worrying'
Older heart patient care 'worrying'
-
Heart Health – Coronary Artery Plaque Removal Guide
Hardening or accumulation of arteries plaque of the heart is called arthrosclerosis in medical term. the plaques develop due to the accumulation of fats in the arterial walls. They are later calcified and the artery narrows thus affecting the blood supply to the organs especially the heart.
-
FDA Says ADHD Medications Are OK
posted by Mindy on 1 Nov 2011 at 11:54 pm
-
Continuous use of nitroglycerin increases severity of heart attacks, Stanford study shows
Public release date: 2-Nov-2011 [ | E-mail | Share ] Contact: Rosanne Spectormanishma@stanford.edu650-725-5374Stanford University Medical Center
-
The Press Association: Older heart patient care 'worrying'
Older heart patient care 'worrying' (UKPA)–Oct 19, 2011
-
Blood Pressure Drugs at Bedtime May Cut Heart Risk – High Blood Pressure (Hypertension) and Related Information on MedicineNet.com
Latest High Blood Pressure News Study Suggests Benefits to Taking Blood Pressure Drugs Before going to Sleep
-
Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
PARSIPPANY, N.J., Oct. 28, 2011 — /PRNewswire/ — Watson Pharmaceuticals, inc. (NYSE: WPI), today confirmed that the United States District Court for the District of Massachusetts has granted Momenta Pharmaceuticals, inc. and Sandoz inc.’s request for a preliminary injunction preventing Watson and Amphastar Pharmaceuticals, inc. from marketing or selling Amphastar’s Enoxaparin Sodium Injection, a generic [...]